I am particularly excited about the breadth of the session content. Issues range from biosimilars, patentability of DNA, and recent Supreme Court decisions. Those representing small biotechs and University Tech Transfer offices can enjoy sessions focused on collaborative R&D, technology transfer, and licensing. Larger biotechs can learn about fighting counterfeiting abroad with the U.S. government and patenting issues in Europe and India. Click on the links below to find out more about these Breakout Sessions: